IO BIOTECH, INC.
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About IOBT
IO Biotech Inc is a clinical-stage biopharmaceutical company developing immune-modulating cancer therapies based on T-win technology platform. The Company’s product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression. IO Biotech’s lead product candidate, IO102-IO103, is designed to target the immunosuppressive mechanisms mediated by key immunosuppressive proteins such as IDO and PD-L1. The Company develops a pipeline of product candidates that leverage its T-win technology platform to address targets within the TME. The Company is spin-off of National Cancer for Center Immune Therapy at Herlev University Hospital in Denmark.
Find out what a historical investment in IO BIOTECH, INC. would be worth today using our IOBT stock calculator.
$65.88M
-
0.00%
119.92K
$1.05
$0.98
$0.99
$1.73
$0.66
Ready to start your investing journey with Stake?
Open an accountIOBT FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in IOBT
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IOBT
on Stake
Buy IOBT from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of IOBT from only US$10 with fractional shares
